ACET
Adicet Bio Inc
6.50$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -28.1% | -2.2% | -3.0% | -0.6% | – | – | -4.8% | +0.0% | -7.9% | -8.9% | – | – | |
| – | – | -114.7% | – | – | – | -151.6% | – | – | – | – | – | – | |
| – | -5.4% | -3.5% | +8.4% | +1.4% | -11.4% | -2.0% | +24.6% | -19.6% | +9.6% | -30.2% | +5.5% | – | |
| – | +2.6% | +2.5% | -0.4% | -0.7% | +8.3% | -5.3% | -43.9% | +28.5% | +34.3% | -40.4% | -5.7% | – | |
| – | -39.6% | -7.4% | +12.4% | +0.9% | -7.3% | -2.8% | +8.4% | -13.7% | +14.1% | -36.6% | +10.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4,800.0% | -95.9% | -100.0% | – | +0.0% | -100.0% | – | – | +100.0% | -4.2% | -4.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +6.1% | -199.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.